Pancreatic Cancer Research

ResearcherHarbin Medical UniversityActive in the last 2 years

Peng Fu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2982-6300; OpenAlex author ID A5007352151. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. Knockdown of LncRNA-HAGLR restrains the viability and motility of pancreatic cancer via miR-625-5p/TAF15 axis in vitro and in vivo. Co-author DOI 10.1016/j.heliyon.2024.e37254↗
  2. Clinical application of Al18F-NOTA-FAPI PET/CT in diagnosis and TNM staging of pancreatic adenocarcinoma, compared to 18F-FDG. Last author DOI 10.1186/s40644-023-00596-1↗
  3. Effects of the silencing of hypoxia-inducible Factor-1 alpha on metastasis of pancreatic cancer. Co-author PMID 23467940↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yue Han · 1 shared paper, 2024 · strength 0.26
  2. Jiafu Wang · 1 shared paper, 2024 · strength 0.26
  3. Zhehao Lyu · 1 shared paper, 2023 · strength 0.18
  4. Xiyong Liu · 1 shared paper, 2013 · strength 0.05
  5. F Li · 1 shared paper, 2013 · strength 0.05
  6. Haiyan Wei · 1 shared paper, 2013 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.